Pall Named Exclusive Distributor of Haemonetics Blood Donor Products in Canada.Business Editors/Health/Medical Writers EAST HILLS, N.Y. & BRAINTREE, Mass.--(BUSINESS WIRE)--Feb. 12, 2004 Pall Corporation Pall Corporation NYSE: PLL, formerly Micro Metallic Company, is an East Hills, New York based global business in the diverse field of filtration, separations and purification. Total revenues for fiscal 2006 were $2 billion, with over 11,000 employees and $56. (NYSE NYSE See: New York Stock Exchange :PLL PLL - phase-locked loop ) and Haemonetics Corporation (NYSE:HAE) today announced that they have entered into an exclusive agreement for Pall to distribute Haemonetics blood donor and laboratory processing equipment and disposables in Canada. The companies did not disclose terms of the agreement. Haemonetics is the world's leading supplier of automated blood processing systems used in the collection of platelets, plasma and red cells. Pall sells blood bags and filters used in manual blood processing to blood centers and hospitals around the world. This agreement expands Pall's product portfolio in Canada and gives Haemonetics access to Pall's established distribution channel and long-standing relationships with the Canadian blood processing community. The companies share a common mission of providing technologies and services to advance the safety, quality, and availability of blood products for transfusion Transfusion Definition Transfusion is the process of transferring whole blood or blood components from one person (donor) to another (recipient). recipients. "We've worked with Pall on ventures for many years, and there is a synergy between our companies," said Peter Allen, President of Haemonetics' Donor Division. "Haemonetics has a high quality, complementary product line. We can leverage Pall's outstanding sales channels in Canada and take a position in a market where today we have no share." Pall Medical's Senior Vice President of Canadian Operations, Bonnie bon·ny also bon·nie adj. bon·ni·er, bon·ni·est Scots 1. Physically attractive or appealing; pretty. 2. Excellent. Quanbury-Duern, added, "The true beneficiaries of our expanded relationship with Haemonetics are our customers. We can now offer them complete solutions for all of their blood processing needs and the convenience of one supplier with an unwavering commitment to their success." Pall is the supplier of integrated manual blood processing bags and blood filters to Canada's blood collection agencies. These agencies collect more than one million units of blood products annually. About Haemonetics Corporation Haemonetics (NYSE: HAE) is a global company engaged in the design, manufacture and worldwide marketing of automated blood processing systems. These systems address important medical markets: surgical blood salvage, blood component collection, plasma collection, and blood component safety. To learn more about Haemonetics' products and markets, visit its web site at http://www.haemonetics.com. About Pall Corporation Pall Corporation is the leader in the rapidly growing field of filtration, separations and purification. Pall's business is organized around two broad markets: Life Sciences and Industrial. The Company provides leading-edge products to meet the demanding needs of customers in biotechnology, pharmaceuticals, transfusion medicine transfusion medicine Blood banking A subspecialty of clinical pathology or internal medicine which is involved in Pt management through administration of blood cells and blood products including fresh-frozen plasma and cryoprecipitate; TM specialists are versant in , semiconductors, municipal drinking water drinking water supply of water available to animals for drinking supplied via nipples, in troughs, dams, ponds and larger natural water sources; an insufficient supply leads to dehydration; it can be the source of infection, e.g. leptospirosis, salmonellosis, or of poisoning, e.g. , aerospace and broad industrial markets. Total revenues are $1.6 billion. The Company headquarters are in East Hills, New York East Hills is a village in Nassau County, New York on the North Shore of Long Island. It is considered part of the Greater Roslyn area, which is anchored by the Village of Roslyn. As of the United States 2000 Census, the village population was 6,842. with operations in more than 30 countries. Further information is available at www.pall.com. This release contains forward looking statements that involve risks and uncertainties, including technological advances in the medical field and standards for transfusion medicine and our ability to successfully implement products that incorporate such advances and standards, product demand, market acceptance, regulatory uncertainties, the effect of economic and political conditions, the impact of competitive products and pricing, blood product reimbursement Reimbursement Payment made to someone for out-of-pocket expenses has incurred. policies and practices, foreign currency exchange rates, changes in customers' ordering patterns, the effect of communicable diseases communicable diseases, illnesses caused by microorganisms and transmitted from an infected person or animal to another person or animal. Some diseases are passed on by direct or indirect contact with infected persons or with their excretions. and the effect of uncertainties in markets outside the U.S. (including Europe and Asia) in which we operate and other risks detailed in the Company's filings with the Securities and Exchange Commission. The forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. are based on estimates and assumptions made by management of the Company and are believed to be reasonable, though are inherently uncertain and difficult to predict. Actual results and experience could differ materially from the forward-looking statements. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion